<DOC>
	<DOCNO>NCT01044914</DOCNO>
	<brief_summary>Pharmacological treatment schizophrenia still characterize certain proportion patient resistant common antipsychotic . Variability individual response range patient experience complete near complete symptom remission subset patient remain treatment-refractory despite extensive drug trial year . The investigator propose take advantage simultaneous acquisition clinical intermediate phenotype ascertain possible contribution SNPs within putative causative gene response treatment quetiapine XR .</brief_summary>
	<brief_title>Genes , Intermediate Phenotypes Response Quetiapine RX</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Provision write informed consent Diagnosis schizophrenia use Structured Clinical Interview Diagnosis Diagnostic Statistical Manual Mental DisordersFourth Edition Male female patient age 18 65 year Female patient childbearing potential must use reliable method contraception negative urine human chorionic gonadotropin test enrollment Able understand comply requirement study Patients cut value PANSS 75 Pregnancy lactation Any DSMIV Axis I disorder define inclusion criterion Patients , opinion investigator , pose imminent risk suicide danger self others Known intolerance lack response quetiapine fumarate , judge investigator Use follow cytochrome P450 3A4 inhibitor 14 day precede enrollment include limited : ketoconazole , itraconazole , fluconazole , erythromycin , clarithromycin , troleandomycin , indinavir , nelfinavir , ritonavir , fluvoxamine saquinavir Use follow cytochrome P450 inducers 14 day precede enrollment include limited : phenytoin , carbamazepine , barbiturate , rifampin , St. John 's Wort , glucocorticoid Administration depot antipsychotic injection within one dose interval randomization Patients treat clozapine within 28 day enrollment Substance alcohol dependence enrollment ( except dependence full remission , except caffeine nicotine dependence ) Opiates , amphetamine , barbiturate , cocaine , cannabis , hallucinogen abuse DSMIV criterion within 4 week prior enrollment Medical condition would affect absorption , distribution , metabolism , excretion study treatment Unstable inadequately treat medical illness ( e.g . diabetes , angina pectoris , hypertension ) judge investigator Involvement planning conduct study Previous enrollment randomization treatment present study Participation another drug trial within 4 week prior enrollment study long accordance local requirement A patient Diabetes Mellitus An absolute neutrophil count Â¬1.5 x 109 per liter Preexisting Organic Mental Disorder Mental Retardation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>